The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience

FIRAT, Sakine; İLKAY, Erdoğan; KAÇMAZ, Fehmi; BİLGİN, Selçuk; Özeke, Özcan; ÖZER, Esra; TURAN, Rahçan Sarper; PAMPAL, HASAN KUTLUK

The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience

Erdoğan İLKAY, (Mesa Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Fehmi KAÇMAZ, (Mesa Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Özcan ÖZEKE, (Tatvan Askeri Hastanesi, Kardiyoloji Kliniği, Bitlis, Türkiye)

Rahçan Sarper TURAN, (Mesa Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Sakine FIRAT, (Mesa Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

HASAN KUTLUK PAMPAL, (Mesa Hastanesi, Kardiyoloji Kliniği, Ankara, Türkiye)

Esra ÖZER, (Mesa Hastanesi, Anesteziyoloji Kliniği, Ankara, Türkiye)

Selçuk BİLGİN (Mesa Hastanesi, Anesteziyoloji Kliniği, Ankara, Türkiye)

Türk Kardiyoloji Derneği Arşivi

3 1

Yıl: 2010 Cilt: 38 Sayı: 3 Sayfa Aralığı: 189 - 193 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience

Öz:

Amaç: Bu çalışmada sekundum tip atriyal septal defektlerin (ASD) kapatılmasında Occlutech Figulla cihazının etkinlik ve güvenliği değerlendirdi.Çalışma planı: Çalışmaya, hemodinamik olarak önemli şanta yol açan sekundum ASD’nin perkütan transkateter yolla kapatılmasında Occlutech Figulla cihazı kullanılan 28 hasta (17 kadın, 11 erkek; ort. yaş 43) alındı. Defekt büyüklüğü transtorasik (TTE) ve transözofageal (TEE) ekokardiyografi yanı sıra sekiz hastada balonla da ölçüldü. Hastalar altı ay izlendi ve TTE ile muayene edildi.Bulgular: Ortalama defekt çapı TTE ile 20.3±2.1 mm, TEE ile 22.1±1.9 mm, balonla 24.2±2.4 mm ölçüldü. Defektlerin kapatılmasında kullanılan ortalama cihaz büyüklüğü 26.8±3.6 mm (dağılım 6-36 mm) idi. Kapatma işlemi ortalama 44.7±21.4 dakika sürdü. Tüm hastalarda cihaz başarıyla yerleştirildi. Cihaz yerleşiminden hemen sonra üç hastada (%10.7) küçük rezidüel akım izlendi; bu durum iki hastada üçüncü ayda, bir hastada ise altıncı ayda kayboldu. İşlem sırasında, üç hastada (%10.7) geçici sinüs taşikardisi ve bir hastada (%3.6) akut atriyal fibrilasyon olmak üzere, dört hastada (%14.3) komplikasyon gelişti. Altıncı ay takibinde tüm hastalar semptomsuzdu. Hiçbir hastada iskemik inme, yırtılma, cihaz aşınması, embolizasyon, trombüs oluşumu ya da cihazın yer değiştirmesi görülmedi.Sonuç: Occlutech Figulla cihazı sekundum tip ASD’lerin kapatılmasında etkin ve güvenli bir cihazdır. Özellikle trombüs gelişimi için yüksek riskli hastalarda tercih edilebilir.

Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi

Sekundum tip atriyal septal defektlerin perkütan kapatılmasında Occlutech Figulla cihazının etkinlik ve güvenliği: İlk klinik deneyimlerimiz

Öz:

Objectives: We evaluated the efficiency and safety of the Occlutech Figulla device in percutaneous closure of secundum atrial septal defects (ASD). Study design: The study included 28 patients (17 women, 11 men; mean age 43 years) who underwent percutaneous transcatheter closure using the Occlutech Figulla device for secundum ASDs causing a hemodynamically significant shunt. Defect size was estimated by transthoracic (TTE) and transesophageal (TEE) echocardiography, and also by balloon sizing in nine patients. The patients were followed-up for six months and were examined by TTE. Results: The mean defect size was 20.3±2.1 mm on TTE, 22.1±1.9 mm on TEE, and 24.2±2.4 mm on balloon sizing. The mean device size was 26.8±3.6 mm (range 6 to 36 mm). The mean procedure time was 44.7±21.4 minutes. The device was placed successfully in all the patients. A small residual flow was seen immediately after device placement in three patients (10.7%), which disappeared in two patients at three months, and in one patient at six months. During the procedure, complications were seen in four patients (14.3%), including transient sinus tachycardia in three patients (10.7%) and acute atrial fibrillation in one patient (3.6%). At six months, all the patients were asymptomatic. No ischemic stroke, cardiac perforation, device erosion, embolization, thrombus formation, or malposition of the device were observed. Conclusion: The Occlutech Figulla occluder is a safe and efficient device to close secundum ASDs. It may be preferred especially in patients with a high risk for thrombus formation.

Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, Tortoriello TA, et al. Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 2002;87:256-9.
2. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-9.
3. Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella. Am J Cardiol 1996;78:1310-2.
4. Rao PS, Berger F, Rey C, Haddad J, Meier B, Walsh KP, et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J Am Coll Cardiol 2000;36:583-92.
5. Rickers C, Hamm C, Stern H, Hofmann T, Franzen O, Schräder R, et al. Percutaneous closure of secundum atrial septal defect with a new self centering device (“angel wings”). Heart 1998;80:517-21.
6. Rome JJ, Keane JF, Perry SB, Spevak PJ, Lock JE. Double-umbrella closure of atrial defects. Initial clinical applications. Circulation 1990;82:751-8.
7. Sommer RJ, Hijazi ZM, Rhodes JF Jr. Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions. Circulation 2008;117:1090-9.
8. Samánek M. Children with congenital heart disease: probability of natural survival. Pediatr Cardiol 1992; 13:152-8.
9. Amin Z, Daufors DA. Balloon sizing is not necessary for closure of secundum atrial septal defects. [Abstract] J Am Coll Cardiol. 2005;45(suppl 1):317.
10. Zanchetta M. On-line intracardiac echocardiography alone for Amplatzer Septal Occluder selection and device deployment in adult patients with atrial septal defect. Int J Cardiol 2004;95:61-8.
11. Wang JK, Tsai SK, Lin SM, Chiu SN, Lin MT, Wu MH. Transcatheter closure of atrial septal defect without balloon sizing. Catheter Cardiovasc Interv 2008;71:214-21.
12. Kim MS, Klein AJ, Carroll JD. Transcatheter closure of intracardiac defects in adults. J Interv Cardiol 2007;20: 524-45.
13. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K; Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002;39:1836-44.
14. Patel A, Lopez K, Banerjee A, Joseph A, Cao QL, Hijazi ZM. Transcatheter closure of atrial septal defects in adults > or =40 years of age: immediate and followup results. J Interv Cardiol 2007;20:82-8.
15. Spies C, Timmermanns I, Schräder R. Transcatheter closure of secundum atrial septal defects in adults with the Amplatzer septal occluder: intermediate and longterm results. Clin Res Cardiol 2007;96:340-6.
16. Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 2005;45:505-7.
17. Halabi A, Hijazi ZM. A new device to close secundum atrial septal defects: first clinical use to close multiple defects in a child. Catheter Cardiovasc Interv 2008;71:853-6.
18. Krecki R, Peruga JZ, Plewka M, Krzemińska-Pakuła M, Kasprzak JD. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke. Cardiol J 2008;15:380-2.
19. Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Figulla HR. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO). Clin Res Cardiol 2008;97:872-7.
20. Çeliker A, Özkutlu S, Karagöz T, Ayabakan C, Bilgiç A. Transcatheter closure of interatrial communications with Amplatzer device: results, unfulfilled attempts and special considerations in children and adolescents. Anadolu Kardiyol Derg 2005;5:159-64.
21. Wang JK, Tsai SK, Wu MH, Lin MT, Lue HC. Shortand intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer septal occluder. Am Heart J 2004;148:511-7.
22. Suda K, Raboisson MJ, Piette E, Dahdah NS, Miró J. Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device. J Am Coll Cardiol 2004;43:1677-82.
23. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-5.
24. Levi DS, Moore JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 2004;61:543-7.
25. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004;63:496-502.
26. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:302-9.
27. Kaya MG, Özdoğru İ, Baykan A, Doğan A, İnanç T, Doğdu O, et al. Transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder in adult patients: our first clinical experiences. [Article in Turkish] Türk Kardiyol Dern Arş 2008;36:287-93.

APA	İLKAY E, KAÇMAZ F, Özeke Ö, TURAN R, FIRAT S, PAMPAL H, ÖZER E, BİLGİN S (2010). The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. , 189 - 193.
Chicago	İLKAY Erdoğan,KAÇMAZ Fehmi,Özeke Özcan,TURAN Rahçan Sarper,FIRAT Sakine,PAMPAL HASAN KUTLUK,ÖZER Esra,BİLGİN Selçuk The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. (2010): 189 - 193.
MLA	İLKAY Erdoğan,KAÇMAZ Fehmi,Özeke Özcan,TURAN Rahçan Sarper,FIRAT Sakine,PAMPAL HASAN KUTLUK,ÖZER Esra,BİLGİN Selçuk The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. , 2010, ss.189 - 193.
AMA	İLKAY E,KAÇMAZ F,Özeke Ö,TURAN R,FIRAT S,PAMPAL H,ÖZER E,BİLGİN S The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. . 2010; 189 - 193.
Vancouver	İLKAY E,KAÇMAZ F,Özeke Ö,TURAN R,FIRAT S,PAMPAL H,ÖZER E,BİLGİN S The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. . 2010; 189 - 193.
IEEE	İLKAY E,KAÇMAZ F,Özeke Ö,TURAN R,FIRAT S,PAMPAL H,ÖZER E,BİLGİN S "The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience." , ss.189 - 193, 2010.
ISNAD	İLKAY, Erdoğan vd. "The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience". (2010), 189-193.

APA	İLKAY E, KAÇMAZ F, Özeke Ö, TURAN R, FIRAT S, PAMPAL H, ÖZER E, BİLGİN S (2010). The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. Türk Kardiyoloji Derneği Arşivi, 38(3), 189 - 193.
Chicago	İLKAY Erdoğan,KAÇMAZ Fehmi,Özeke Özcan,TURAN Rahçan Sarper,FIRAT Sakine,PAMPAL HASAN KUTLUK,ÖZER Esra,BİLGİN Selçuk The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. Türk Kardiyoloji Derneği Arşivi 38, no.3 (2010): 189 - 193.
MLA	İLKAY Erdoğan,KAÇMAZ Fehmi,Özeke Özcan,TURAN Rahçan Sarper,FIRAT Sakine,PAMPAL HASAN KUTLUK,ÖZER Esra,BİLGİN Selçuk The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. Türk Kardiyoloji Derneği Arşivi, vol.38, no.3, 2010, ss.189 - 193.
AMA	İLKAY E,KAÇMAZ F,Özeke Ö,TURAN R,FIRAT S,PAMPAL H,ÖZER E,BİLGİN S The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. Türk Kardiyoloji Derneği Arşivi. 2010; 38(3): 189 - 193.
Vancouver	İLKAY E,KAÇMAZ F,Özeke Ö,TURAN R,FIRAT S,PAMPAL H,ÖZER E,BİLGİN S The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience. Türk Kardiyoloji Derneği Arşivi. 2010; 38(3): 189 - 193.
IEEE	İLKAY E,KAÇMAZ F,Özeke Ö,TURAN R,FIRAT S,PAMPAL H,ÖZER E,BİLGİN S "The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience." Türk Kardiyoloji Derneği Arşivi, 38, ss.189 - 193, 2010.
ISNAD	İLKAY, Erdoğan vd. "The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: Initial clinical experience". Türk Kardiyoloji Derneği Arşivi 38/3 (2010), 189-193.